Hansa Biopharma AB (publ) (HNSA.ST) Description, Stock price, News & Info.

#ThinkSabio Latest News

Hansa Biopharma completes enrolment in European Phase 3 20-HMedIdeS-19 Post Authorization Efficacy and Safety study in highly sensitized kidney transplant patients